Epigenetic control of chromosome instability by STAT3 in gastric cancer

被引：0
|
作者：
Chuang, Yu Ming [1 ,2 ]
Hung, Sheng-Jou [3 ]
Chou, Jiang Liang [4 ]
Huang, Wan-Hong [1 ,2 ]
Yan, Pearlly S. [5 ]
Liu, Tsunglin [3 ]
Chan, Michael W. Y. [1 ,2 ]
机构：
[1] Natl Chung Cheng Univ, Dept Biomed Sci, Chiayi, Taiwan
[2] Natl Chung Cheng Univ, Ctr Innovat Res Aging Soc, Chiayi, Taiwan
[3] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan
[4] Chang Gung Mem Hosp, Div Gastroenterol, Taoyuan, Taiwan
[5] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-4326
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4326
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer
    Liu, Yong
    Deng, Jingyu
    Luo, Xuegang
    Pan, Yuan
    Zhang, Li
    Zhang, Rupeng
    Liang, Han
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 11
  • [22] Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activity
    Xu, Jiaxin
    Chen, Yunhe
    Yang, Rui
    Zhou, Tong
    Ke, Wei
    Si, Yuan
    Yang, Shusheng
    Zhang, Te
    Liu, Xuewen
    Zhang, Liang
    Xiang, Ke
    Guo, Yang
    Liu, Ying
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2020, 684
  • [23] Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer
    Xiong, Hua
    Du, Wan
    Wang, Ji-Lin
    Wang, Ying-Chao
    Tang, Jie-Ting
    Hong, Jie
    Fang, Jing-Yuan
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2012, 90 (09): : 1037 - 1046
  • [24] STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects
    Ashrafizadeh, Milad
    Zarrabi, Ali
    Orouei, Sima
    Zarrin, Vahideh
    Moghadam, Ebrahim Rahmani
    Zabolian, Amirhossein
    Mohammadi, Shima
    Hushmandi, Kiavash
    Gharehaghajlou, Yashar
    Makvandi, Pooyan
    Najafi, Masoud
    Mohammadinejad, Reza
    BIOLOGY-BASEL, 2020, 9 (06): : 1 - 43
  • [25] Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer
    Hua Xiong
    Wan Du
    Ji-Lin Wang
    Ying-Chao Wang
    Jie-Ting Tang
    Jie Hong
    Jing-Yuan Fang
    Journal of Molecular Medicine, 2012, 90 : 1037 - 1046
  • [26] Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer
    Wei, Kuo-Liang
    Chou, Jian-Liang
    Chen, Yin-Chen
    Jin, Hongchuan
    Chuang, Yu-Min
    Wu, Cheng-Shyong
    Chan, Michael W. Y.
    PLOS ONE, 2019, 14 (06):
  • [27] Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1
    Song, Shiyu
    Su, Zhonglan
    Xu, Hui
    Niu, Mengyuan
    Chen, Xiufang
    Min, Haiyan
    Zhang, Bin
    Sun, Guibo
    Xie, Sijing
    Wang, Hongwei
    Gao, Qian
    CELL DEATH & DISEASE, 2017, 8 : e2612 - e2612
  • [28] Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1
    Shiyu Song
    Zhonglan Su
    Hui Xu
    Mengyuan Niu
    Xiufang Chen
    Haiyan Min
    Bin Zhang
    Guibo Sun
    Sijing Xie
    Hongwei Wang
    Qian Gao
    Cell Death & Disease, 2017, 8 : e2612 - e2612
  • [29] Targeting STAT3 and STAT5 in Cancer
    de Araujo, Elvin D.
    Keseru, Gyorgy M.
    Gunning, Patrick T.
    Moriggl, Richard
    CANCERS, 2020, 12 (08)
  • [30] STAT3 promotes a youthful epigenetic state in articular chondrocytes
    Sarkar, Arijita
    Liu, Nancy Q.
    Magallanes, Jenny
    Tassey, Jade
    Lee, Siyoung
    Shkhyan, Ruzanna
    Lee, Youngjoo
    Lu, Jinxiu
    Ouyang, Yuxin
    Tang, Hanhan
    Bian, Fangzhou
    Tao, Litao
    Segil, Neil
    Ernst, Jason
    Lyons, Karen
    Horvath, Steve
    Evseenko, Denis
    AGING CELL, 2023, 22 (02)
12345